Proprietary community pharmacy patient data warehouse, authorized by the CNIL. Representative of the French population. Daily data updates. Longitudinal tracking at the patient and pharmacy level. Project launched in under 2 months.
SOG Health collects daily pseudonymized data from pharmacy management software across metropolitan France, providing a unique longitudinal view of patients' therapeutic management in the community setting — regardless of the prescriber (hospital or private practice, GP or specialist).
Medications, medical devices, dispensing dates, products, dosages, pack sizes and quantities dispensed.
Sex, age groups, region and department of the pharmacy. Comorbidities identified on the basis of therapeutic markers.
Specialty and practice type of the prescriber (private vs. hospital, GP vs. specialist).
Complete history of vaccinations administered in community pharmacies: flu, Covid-19, RSV, chikungunya, shingles and adult boosters.
Calculation of the MPR (Medication Possession Ratio), analysis of persistence and treatment discontinuation at N months.
SOG Health meets the needs of Studies / Marketing, Medical Affairs, Market Access and HEOR teams.
Tracking volumes and market share by treatment, treatment dynamics (new patients, renewals, switches), therapeutic patterns and source of dispensing.
Quantification of adherence and persistence at N months, description of outcomes for patients who discontinue treatment, analysis of discontinuation and treatment switch factors.
Real-time vaccination rates by age group, region and patient profile. Weekly tracking of national campaigns with inter-season comparison and impact of new recommendations.
SOG Health enables real-time monitoring of patients' therapeutic management in community pharmacies. These recurring observatories are available by subscription, under a single decision from the EDS Scientific Committee.
SOG Health is an EDS authorized by the CNIL (deliberation N° 2025-014) and accessible to all stakeholders in the healthcare ecosystem (academics, health authorities and industry). Data is transmitted daily by 85% of community pharmacies in compliance with GDPR. Projects eligible for MR-004 are subject to validation by the EDS Scientific Committee or covered by single decisions.
Whether you want to subscribe to a recurring observatory or conduct a custom study, we support you at every step.
A simple subscription with delivery, at your preferred frequency, of key indicators on your therapeutic area.
Identification of the therapeutic area of interest and desired indicators.
1 weekDelivery of an observatory mock-up to validate the format and content, with a commercial proposal.
1–2 weeksSetting up the subscription after signing regulatory documents.
1 weekAutomatic receipt of indicators at the agreed frequency (monthly or quarterly).
OngoingAn observational, epidemiological or pharmaco-economic study on SOG Health data, from feasibility to publication.
Free feasibility study on SOG Health data.
1–2 weeksProtocol writing and submission to the EDS Scientific Committee (MR-004).
4–6 weeksCohort assembly and extraction of variables according to the validated protocol.
2–3 weeksDescriptive analyses and modeling according to the statistical plan.
6–10 weeksFinal report, congress support and submission to a peer-reviewed journal.
4–6 weeksContact our team to discuss the feasibility of your study or receive an observatory specimen on your therapeutic area.